Microbix Biosystems (TSE:MBX) Stock Price Down 4.2%

Microbix Biosystems Inc (TSE:MBX) traded down 4.2% during mid-day trading on Tuesday . The company traded as low as C$0.23 and last traded at C$0.23, 8,500 shares changed hands during trading. A decline of 91% from the average session volume of 89,884 shares. The stock had previously closed at C$0.24.

The company has a debt-to-equity ratio of 67.61, a current ratio of 1.38 and a quick ratio of 0.36. The company has a market capitalization of $24.24 million and a PE ratio of -3.08. The firm’s fifty day simple moving average is C$0.24 and its 200 day simple moving average is C$0.26.

Microbix Biosystems Company Profile (TSE:MBX)

Microbix Biosystems Inc, a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. The company produces infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry; controls for diagnostic assays.

See Also: Capital Gains Distribution

Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.